Loading...
Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles
The clinical application of cis-diamminedichloroplatinum(II) (DDP, cisplatin) for cancer therapy is limited by its non-specific biodistribution and severe side effects. Here, we have developed EGFR-targeted heparin-DDP (EHDDP) nanoparticles for tumor targeted delivery of DDP. This nanoparticle deliv...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3275811/ https://ncbi.nlm.nih.gov/pubmed/22032622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/nn202410f |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|